drug development

Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters
Gilead Sciences
drug development
remdesivir
COVID-19
Flag link:
Regeneron to expand development deal with Intellia Therapeutics
Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Regeneron
Intellia Therapeutics
hemophilia A
hemophilia B
CRISPR
drug development
Flag link:
The WHO launched a voluntary Covid-19 product pool. What happens next?
The WHO launched a voluntary Covid-19 product pool. What happens next?
Stat
WHO
COVID-19
patents
drug development
pandemic
Flag link:
U.S. is ahead of China in vaccine race, former FDA chief says
U.S. is ahead of China in vaccine race, former FDA chief says
Politico
China
vaccines
COVID-19
drug development
Scott Gottlieb
Flag link:
Covid-19 has exposed the limits of the pharmaceutical market model
Covid-19 has exposed the limits of the pharmaceutical market model
Stat
pharma marketing
Gilead Sciences
remdesivir
COVID-19
drug development
pandemics
Flag link:
FDA issues two guidances to accelerate COVID-19 treatments
FDA issues two guidances to accelerate COVID-19 treatments
RAPS.org
FDA
drug development
COVID-19
coronaviruses
Flag link:
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Fierce Pharma
Regeneron
COVID-19
Kevzara
Pharma CEOs
drug development
vaccines
pandemic
Len Schleifer
Flag link:
Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work
Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work
Fierce Pharma
Novavax
CEPI
grants
COVID-19
vaccines
drug development
Flag link:
What's it like to work on J&J's coronavirus vaccine? For one scientist, it's social distancing in the lab, late nights at home
What's it like to work on J&J's coronavirus vaccine? For one scientist, it's social distancing in the lab, late nights at home
Fierce Pharma
JNJ
drug development
vaccines
R&D
COVID-19
Flag link:
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
Flag link:
COVID-19 Crowding Out Non-COVID-19 Healthcare And Drug Development
COVID-19 Crowding Out Non-COVID-19 Healthcare And Drug Development
Forbes
COVID-19
pandemic
drug development
R&D
Flag link:
Antibiotic pipeline in peril from coronavirus and incentives system
Antibiotic pipeline in peril from coronavirus and incentives system
Axios
antibiotics
drug development
COVID-19
pandemic
Flag link:
Faster Drug Development Processes Likely to Outlive COVID-19
Faster Drug Development Processes Likely to Outlive COVID-19
BioSpace
drug development
pandemic
COVID-19
Flag link:
A COVID-19 treatment inspired by llamas
A COVID-19 treatment inspired by llamas
Fierce Biotech
COVID-19
antibodies
drug development
nanobodies
NIH
animal research
Flag link:
Coronavirus vaccine: how pharma is picking up the pace
Coronavirus vaccine: how pharma is picking up the pace
Pharmaforum
COVID-19
vaccines
drug development
Flag link:
Big Pharma wants billions more for COVID-19 funding pot
Big Pharma wants billions more for COVID-19 funding pot
Fierce Pharma
Big Pharma
coronaviruses
COVID-19
vaccines
drug development
government funding
Flag link:
A bullseye from 24 feet? COVID-19 vaccine timelines are overly hopeful, analyst says
A bullseye from 24 feet? COVID-19 vaccine timelines are overly hopeful, analyst says
Fierce Pharma
vaccines
COVID-19
drug development
Flag link:
British government enlists AstraZeneca, BIA for new pandemic vaccine taskforce
British government enlists AstraZeneca, BIA for new pandemic vaccine taskforce
Fierce Biotech
COVID-19
UK
vaccines
drug development
AstraZeneca
Flag link:
NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines
NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines
Stat
NIH
vaccines
drug development
pandemic
COVID-19
R&D
Flag link:
WHO: There Are 70 Coronavirus Vaccines Currently in Development
WHO: There Are 70 Coronavirus Vaccines Currently in Development
Motley Fool
WHO
vaccines
drug development
COVID-19
pandemic
Moderna Therapeutics
Flag link:

Pages